highly significantp ≤ 0.001
Clinical Course/Secondary endpoints Looking at the transfusion frequency in the first 24 h, the subgroups age > 50 years showed a highly significant difference (ESS ≥ 16: 59.86%/ESS < 16: 20.37%, p ≤ 0.001) (Table 3 ).
Clinical Course/Secondary endpoints Looking at the transfusion frequency in the first 24 h, the subgroups age > 50 years showed a highly significant difference (ESS ≥ 16: 59.86%/ESS < 16: 20.37%, p ≤ 0.001) (Table 3 ).
The expected lethality, represented by the RISC2 showed a higher value for the ESS < 16 group, however this did not reach statistical significance.